ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1458

Functional Phenotype of Synovial Monocytes Modulating Inflammatory T-Cell Response in Rheumatoid Arthritis

Seong-Wook Kang1, Seung-Cheol Shim1, Jinhyun Kim1, In-Seol Yoo2, Su-Jin Yoo2, Seung-Taek Song1, Bo-Ruem Yoon3 and Won-Woo Lee3, 1Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, South Korea, 2Departmen of Internal medicine, Chungnam National University School of Medicine, Daejeon, South Korea, 3Department of Microbiology and Immunology, Seoul National University College of Medicine, Seoul, South Korea

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: monocytes and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Title: Rheumatoid Arthritis - Human Etiology and Pathogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose

Monocytes function as crucial innate effectors during inflammation. Human monocytes can be divided into three distinct subsets based on CD14 and CD16 expression. Accumulating evidences suggest that three monocyte subsets have distinct functions in inflammatory responses. Here we investigated the characteristics of monocytes in synovial fluid (SF) of rheumatoid arthritis (RA) patients.

Methods

Monocytes and T cells were separated from the peripheral blood (PB) and SF obtained from patients with RA and analyzed by using flow cytometry. For global transcriptome analysis of pathogenic monocytes in RA, we performed a microarray analysis of SF and PB monocytes from the same RA patients and PB monocytes of healthy control (HC).

Results

CD16 expression on CD14++ monocytes in the SF was significantly increased compared with that in the PB of RA patients and HC. Microarray data showed that 3,134 genes were differentially expressed in SF monocytes compared with PB monocytes from RA and HC. Among the genes, CD80 and CD276 expression were significantly elevated on SF monocytes, while PB monocytes of RA and HC did not express both of them without stimulation. CD80 and CD276 belong to the B7 family, which plays a checkpoint role for modulating T-cell responses. To explore how SF monocytes gain unique properties, PB monocytes were stimulated with various cytokines and TLR ligands. TGF-β is a potent inducer of CD16 expression on CD14++ monocytes, whereas expressions of CD80 and CD276 were markedly elevated by IFN-γ and GM-CSF, respectively. In vitro assay, SF monocytes were found to significantly promote Th17 and Th1 responses, compared with PB monocytes of RA patients.

Conclusion

Our findings suggest the possible role for cytokine milieu of the synovial fluid in giving unique features to SF monocytes and their cardinal roles in affecting inflammatory T-cell response in RA.


Disclosure:

S. W. Kang,
None;

S. C. Shim,
None;

J. Kim,
None;

I. S. Yoo,
None;

S. J. Yoo,
None;

S. T. Song,
None;

B. R. Yoon,
None;

W. W. Lee,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/functional-phenotype-of-synovial-monocytes-modulating-inflammatory-t-cell-response-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology